JPH04342519A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH04342519A JPH04342519A JP3178277A JP17827791A JPH04342519A JP H04342519 A JPH04342519 A JP H04342519A JP 3178277 A JP3178277 A JP 3178277A JP 17827791 A JP17827791 A JP 17827791A JP H04342519 A JPH04342519 A JP H04342519A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- extract
- effects
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 35
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 12
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 12
- 241000411851 herbal medicine Species 0.000 claims description 10
- 235000003276 Apios tuberosa Nutrition 0.000 claims description 5
- 241001300423 Strophostyles Species 0.000 claims description 5
- 241000946641 Allium canadense var. mobilense Species 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 23
- 239000003814 drug Substances 0.000 abstract description 19
- 229940079593 drug Drugs 0.000 abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 12
- 239000006071 cream Substances 0.000 abstract description 10
- 235000019441 ethanol Nutrition 0.000 abstract description 10
- 239000006210 lotion Substances 0.000 abstract description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 9
- 239000007787 solid Substances 0.000 abstract description 8
- 102000003425 Tyrosinase Human genes 0.000 abstract description 7
- 108060008724 Tyrosinase Proteins 0.000 abstract description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 6
- 230000009759 skin aging Effects 0.000 abstract description 5
- 235000011187 glycerol Nutrition 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- -1 pack Substances 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 239000012459 cleaning agent Substances 0.000 abstract description 2
- 239000006185 dispersion Substances 0.000 abstract description 2
- 239000012046 mixed solvent Substances 0.000 abstract description 2
- 239000002674 ointment Substances 0.000 abstract description 2
- 240000007185 Albizia julibrissin Species 0.000 abstract 1
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 1
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241001662414 Aster tataricus Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000689272 Senna sophera Species 0.000 abstract 1
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 21
- 230000002087 whitening effect Effects 0.000 description 14
- 239000000203 mixture Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 206010014970 Ephelides Diseases 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940069765 bean extract Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 230000037393 skin firmness Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- OFZCIYFFPZCNJE-UHFFFAOYSA-N carisoprodol Chemical compound NC(=O)OCC(C)(CCC)COC(=O)NC(C)C OFZCIYFFPZCNJE-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は特定のマメ科及びキク科
植物由来の生薬の抽出物を含有して成る美白効果、皮膚
老化防止効果、肌あれ改善効果等に優れた皮膚化粧料に
関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to skin cosmetics containing extracts of herbal medicines derived from specific leguminous and asteraceous plants, which have excellent whitening effects, skin aging prevention effects, skin roughness improvement effects, etc.
【0002】0002
【従来の技術及び発明が解決しようとする課題】従来、
美白化粧料には、主としてアスコルビン酸、グルタチオ
ン、コロイドイオウ等が配合されており、このような美
白化粧料は皮膚の色黒、シミ、ソバカスの防止等美容効
果を得るうえで極めて有用である。しかしながら、アス
コルビン酸は酸化されやすいため、一定の効果の発現が
期待しにくいばかりか、化粧料自身が変色してしまうこ
とがある。また、グルタチオンやコロイドイオウは特有
の異臭及び剤型によっては沈澱等が生じるという欠点を
有している。[Prior art and problems to be solved by the invention] Conventionally,
Whitening cosmetics mainly contain ascorbic acid, glutathione, colloidal sulfur, etc., and these whitening cosmetics are extremely useful in obtaining beauty effects such as preventing dark skin, age spots, and freckles. However, since ascorbic acid is easily oxidized, not only is it difficult to expect a certain effect, but the cosmetic itself may change color. Furthermore, glutathione and colloidal sulfur have drawbacks such as a peculiar odor and precipitation depending on the dosage form.
【0003】また、最近生薬等の天然物を化粧料に配合
し、美白効果を得ようとする試みがなされている(特開
昭53−88333号、特開昭54−2344号、特開
昭57−163307号、特開昭60−104005号
、フレグランス ジャーナル臨時増刊No.6(19
86)p164−166)。これら生薬は安全性が高い
ことからその有用性が期待されているものの、その美白
効果は未だ不十分であった。[0003] Recently, attempts have also been made to obtain whitening effects by incorporating natural products such as crude drugs into cosmetics (Japanese Patent Application Laid-open Nos. 88333-1983, 2344-1980, 2003-1983). No. 57-163307, JP-A No. 60-104005, Fragrance Journal Extra Edition No. 6 (19
86) p164-166). Although these herbal medicines are expected to be useful because of their high safety, their whitening effects are still insufficient.
【0004】従って、美白効果に優れ、安全性、色、匂
い等に問題のない生薬配合の皮膚化粧料の開発が望まれ
ていた。[0004]Therefore, it has been desired to develop skin cosmetics containing crude drugs that have excellent whitening effects and have no problems with safety, color, odor, etc.
【0005】[0005]
【課題を解決するための手段】斯かる実情に鑑み、本発
明者らは生薬の抽出物について、美白作用等につき鋭意
研究した結果、特定のマメ科及びキク科植物由来の生薬
の抽出物が高いチロシナーゼ活性阻害作用を有しており
、これらを配合した化粧料は美白効果に優れ、しかも安
全性、安定性に優れていることを見いだし、本発明を完
成した。[Means for Solving the Problems] In view of the above-mentioned circumstances, the present inventors have conducted extensive research on the whitening effect, etc. of extracts of crude drugs, and have found that extracts of crude drugs derived from specific Fabaceae and Asteraceae plants. They have found that they have a high tyrosinase activity inhibiting effect, and that cosmetics containing them have excellent whitening effects, as well as safety and stability, and have completed the present invention.
【0006】すなわち、本発明は山豆根、合歓皮、山扁
豆、蒼耳子、紫おん及び茵ちん蒿から選ばれる生薬の抽
出物の一種又は二種以上を含有することを特徴とする皮
膚化粧料を提供するものである。That is, the present invention provides a skin characterized by containing one or more extracts of herbal medicines selected from mountain bean root, hehuanpi, mountain bean, cang'erzi, ziongian and 茵chinchiang. It provides cosmetics.
【0007】本発明の皮膚化粧料に用いる山豆根、合歓
皮、山扁豆、蒼耳子、紫おん及び茵ちん蒿から得られる
生薬抽出物の調製法は特に限定されないが、例えば種々
の適当な溶媒を用いて室温〜加温下で抽出される。抽出
溶媒としては、例えば水;メチルアルコール、エチルア
ルコール等の低級一価アルコール;グリセリン、プロピ
レングリコール、1,3−ブチレングリコール等の液状
多価アルコール;酢酸エチル等の低級アルキルエステル
;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテル
等のエーテル類等の一種又は二種以上を用いることがで
きる。就中、水又は水溶性溶媒、特に水、エチルアルコ
ール、グリセリン、1,3−ブチレングリコールの一種
又は二種以上の混合溶媒が好ましい。また抽出条件とし
ては、生薬に対し容量比で1〜1000倍量、特に5〜
100倍量の溶媒を用い、4℃以上、特に15〜30℃
の温度で1時間以上、特に1〜3日間行うのが好ましい
。[0007] The preparation method of the herbal medicine extract obtained from wild bean root, hehuanpi, mountain bean, cang'uizhi, purple onion, and 茵chinchiang used in the skin cosmetics of the present invention is not particularly limited, but for example, various suitable methods can be used. Extracted using a suitable solvent at room temperature to elevated temperature. Extraction solvents include, for example, water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; benzene, hexane, etc. hydrocarbons; one or more of ethers such as diethyl ether can be used. Among these, water or a water-soluble solvent, particularly one or a mixed solvent of two or more of water, ethyl alcohol, glycerin, and 1,3-butylene glycol, is preferred. In addition, the extraction conditions are 1 to 1000 times the volume of the crude drug, especially 5 to 1000 times the volume of the crude drug.
Using 100 times the amount of solvent, at 4°C or higher, especially at 15 to 30°C
It is preferable to carry out the treatment at a temperature of 1 hour or more, particularly for 1 to 3 days.
【0008】以上のような条件で得られる生薬抽出物は
、抽出された溶液のまま用いても良いが、さらに必要に
より濃縮、濾過等の処理をしたものを適宜使い分けて用
いることができる。[0008] The crude drug extract obtained under the above conditions may be used as it is as an extracted solution, but it can also be used after further treatment such as concentration and filtration if necessary.
【0009】本発明における上記生薬抽出物は何れも美
白効果を有するが、山扁豆及び茵ちん蒿の抽出物は、こ
れに加えて、活性酸素除去作用による皮膚老化防止効果
及び肌あれ改善効果を有する。従って、上記生薬抽出物
はその効果を期待する皮膚化粧料に配合される。[0009] All of the above herbal medicine extracts in the present invention have a whitening effect, but in addition to this, the extracts of mountain bean and Chinese chinensis also have an anti-aging effect on the skin and an effect on improving rough skin due to active oxygen scavenging action. have Therefore, the above-mentioned herbal medicine extracts are incorporated into skin cosmetics that are expected to have these effects.
【0010】本発明の皮膚化粧料における生薬抽出物の
含有量は、乾燥固形分に換算して0.0001〜10.
0重量%が好ましく、特に0.01〜5.0重量%の範
囲が好ましい。含有量が0.0001重量%未満である
と効果が十分発揮されず、10.0重量%を超えると効
果はほぼ一定となる。[0010] The content of the herbal medicine extract in the skin cosmetic of the present invention is 0.0001 to 10.0% in terms of dry solid content.
0% by weight is preferred, and a range of 0.01 to 5.0% by weight is particularly preferred. If the content is less than 0.0001% by weight, the effect will not be sufficiently exhibited, and if the content exceeds 10.0% by weight, the effect will be almost constant.
【0011】本発明の皮膚化粧料は、上記必須成分の他
、通常化粧品、医薬部外品、医薬品に用いられる水性成
分、粉末、界面活性剤、油剤、保湿剤、アルコール、p
H調整剤、防腐剤、酸化防止剤、増粘剤、色素、香料等
を必要に応じて適宜配合することにより調製される。[0011] In addition to the above-mentioned essential ingredients, the skin cosmetic of the present invention contains aqueous ingredients, powders, surfactants, oils, moisturizers, alcohol, and pylori, which are commonly used in cosmetics, quasi-drugs, and pharmaceuticals.
It is prepared by appropriately blending H regulators, preservatives, antioxidants, thickeners, pigments, fragrances, etc. as necessary.
【0012】本発明の皮膚化粧料の剤型は特に限定され
ず、化粧水、乳液、クリーム、パック、軟膏、分散液、
洗浄料等種々の剤型とすることができる。The dosage form of the skin cosmetic of the present invention is not particularly limited, and may include lotions, milky lotions, creams, packs, ointments, dispersions,
It can be made into various formulations such as cleaning agents.
【0013】また、本発明の皮膚化粧料は、必要により
さらに公知の薬剤を添加してもよい。この薬剤としては
、例えば、アスコルビン酸、グルタチオン及びこれらの
それぞれの誘導体、プラセンタエキス、当帰エキス、桑
白皮エキス、アロエエキス等の美白効果を有する薬剤;
グリチルレチン酸及びその誘導体、インドメタシン等の
抗炎症剤;ウロカニン酸、ベンゾフェノン、パラアミノ
安息香酸、桂皮酸及びこれらのそれぞれの誘導体等の紫
外線吸収剤;ビタミンE、ローズマリーエキス、茶エキ
ス等の酸化防止剤等が挙げられる。これら薬剤は単独で
も二種以上を組み合わせて用いてもよい。[0013] Furthermore, the skin cosmetic of the present invention may further contain known drugs if necessary. Examples of the drug include drugs having a whitening effect such as ascorbic acid, glutathione and their respective derivatives, placenta extract, toki extract, mulberry bark extract, and aloe extract;
Anti-inflammatory agents such as glycyrrhetinic acid and its derivatives, indomethacin; UV absorbers such as urocanic acid, benzophenone, para-aminobenzoic acid, cinnamic acid and their respective derivatives; antioxidants such as vitamin E, rosemary extract, tea extract, etc. etc. These drugs may be used alone or in combination of two or more.
【0014】[0014]
【実施例】次に試験例及び実施例を挙げて本発明をさら
に詳細に説明するが、本発明はこれらに限定されるもの
ではない。EXAMPLES Next, the present invention will be explained in more detail with reference to test examples and examples, but the present invention is not limited thereto.
【0015】試験例1 チロシナーゼ活性阻害試
験:表1に示す如き乾燥した各生薬の細切20重量部に
抽出溶媒80重量部を加え、室温で時々攪拌しながら3
日間抽出し、濾過して各生薬抽出液を得た。これら各生
薬抽出液を試料とし、下記測定方法によりチロシナーゼ
活性阻害率を測定した。結果を表1に示す。
<測定方法>各試料0.1〜0.2mlに酵素溶液〔シ
グマ社製、28000単位のチロシナーゼ10mgを0
.1Mリン酸緩衝液(pH6.8)20mlに溶解した
もの〕0.1mlを加え、さらに0.1Mリン酸緩衝液
(pH6.8)を加え4mlとし、これを25℃にて1
0分間インキュベートした。これに、あらかじめ25℃
に保っておいた基質溶液〔L−DOPA(東京化成)1
98.0mgを0.1Mリン酸緩衝液(pH6.8)1
00mlに溶解したもの〕1.0mlを加え、10分間
反応せしめた。次いで475nmにおける吸光度(OD
S )を測定した。さらに加熱失活させた前記酵素を用
いて同様に反応させた吸光度(ODHE)及び試料無添
加のときの吸光度(ODB )を測定し、次式よりチロ
シナーゼ活性の阻害率を算出した。Test Example 1 Tyrosinase activity inhibition test: 80 parts by weight of extraction solvent was added to 20 parts by weight of each dried herbal medicine shown in Table 1, and the mixture was stirred occasionally at room temperature for 3 hours.
The extracts were extracted for several days and filtered to obtain extracts of each crude drug. Using each of these crude drug extracts as samples, the inhibition rate of tyrosinase activity was measured by the following measurement method. The results are shown in Table 1. <Measurement method> Add 10 mg of tyrosinase (manufactured by Sigma, 28,000 units) to 0.1 to 0.2 ml of each sample.
.. Add 0.1 ml of the solution dissolved in 20 ml of 1M phosphate buffer (pH 6.8), and add 0.1M phosphate buffer (pH 6.8) to make 4 ml.
Incubated for 0 minutes. Add this to 25℃ in advance.
Substrate solution [L-DOPA (Tokyo Kasei) 1
98.0 mg in 0.1 M phosphate buffer (pH 6.8) 1
1.0 ml of the solution] was added and reacted for 10 minutes. Then the absorbance at 475 nm (OD
S ) was measured. Furthermore, the absorbance (ODHE) of a similar reaction using the heat-inactivated enzyme and the absorbance (ODB) when no sample was added were measured, and the inhibition rate of tyrosinase activity was calculated from the following formula.
【0016】[0016]
【数1】[Math 1]
【0017】[0017]
【表1】[Table 1]
【0018】表1の結果より明らかな如く、本発明に用
いる山豆根、合歓皮、山扁豆、蒼耳子、紫おん、茵ちん
蒿の抽出物は、チロシナーゼを抑制し、ドーパクローム
の生成を低下させ、高い美白効果を有していた。[0018] As is clear from the results in Table 1, the extracts of wild bean root, hehuanpi, mountain bean, cang'erzi, purple onion, and chinchen used in the present invention inhibit tyrosinase and inhibit the production of dopachrome. It had a high whitening effect.
【0019】試験例2 活性酸素除去効果試験:
表2に示す乾燥した各生薬の細切20重量部にエチルア
ルコール、50%(v/v)エチルアルコール水溶液又
は水80重量部を加え、室温で時々攪拌しながら3日間
抽出し、濾過して各生薬抽出液を得た。これらの各生薬
抽出液を試料とし、下記測定方法により、活性酸素除去
率を測定した。結果を表2に示す。
<測定方法>0.05M炭酸ナトリウム緩衝液(pH1
0.2)2.4mlに基質溶液〔3.0mMキサンチン
(0.05M炭酸ナトリウム緩衝液に溶解)〕0.1m
l、3.0mMEDTA 0.1ml、0.15%(
w/v)ウシ血清アルブミン0.1ml、0.75mM
ニトロブルーテトラゾリウム0.1ml及び各試料
を0.1ml混合し、25℃で10分間放置した後、酵
素溶液〔キサンチンオキシダーゼ溶液(精製水にて約0
.04units/ml希釈)〕0.1mlを加えて反
応を開始する。25℃で20分間インキュベートした後
、6mM CuCl2 0.1mlを加えて反応を停
止する。次いで560nmにおける吸光度(A)を測定
する。対照には、試料のかわりに精製水を加えた吸光度
(B)、また各試料のブランクには、6mM CuC
l2 0.1mlを加えて反応停止後に、キサンチンオ
キシダーゼ0.1mlを添加した吸光度(C)を測定し
、次式より活性酸素除去率を算出した。Test Example 2 Active oxygen removal effect test:
Ethyl alcohol, 50% (v/v) aqueous ethyl alcohol solution, or 80 parts by weight of water was added to 20 parts by weight of each dried crude drug shown in Table 2, extracted with occasional stirring for 3 days at room temperature, and filtered. Extracts of each crude drug were obtained. Using each of these herbal medicine extracts as samples, the active oxygen removal rate was measured by the following measurement method. The results are shown in Table 2. <Measurement method> 0.05M sodium carbonate buffer (pH 1
0.2) Add 0.1m of substrate solution [3.0mM xanthine (dissolved in 0.05M sodium carbonate buffer)] to 2.4ml.
l, 3.0mM EDTA 0.1ml, 0.15% (
w/v) bovine serum albumin 0.1ml, 0.75mM
Mix 0.1 ml of nitro blue tetrazolium and 0.1 ml of each sample, leave to stand at 25°C for 10 minutes, and dilute the enzyme solution [xanthine oxidase solution (approx.
.. 0.04 units/ml dilution)] to start the reaction. After incubating for 20 minutes at 25°C, the reaction is stopped by adding 0.1 ml of 6mM CuCl2. The absorbance (A) at 560 nm is then measured. For the control, the absorbance (B) was obtained by adding purified water instead of the sample, and for each sample blank, 6mM CuC
After 0.1 ml of 12 was added to stop the reaction, 0.1 ml of xanthine oxidase was added, the absorbance (C) was measured, and the active oxygen removal rate was calculated from the following formula.
【0020】[0020]
【数2】[Math 2]
【0021】[0021]
【表2】[Table 2]
【0022】表2の結果より明らかな如く、本発明に用
いる山扁豆及び茵ちん蒿の抽出物は活性酸素を除去し、
高いSOD様抗酸化活性を有していた。[0022] As is clear from the results in Table 2, the extracts of mountain bean and Chinese bean used in the present invention remove active oxygen,
It had high SOD-like antioxidant activity.
【0023】実施例1 化粧水:<組成>
(重量%)(1)グリセリン
5.0(2)1,3−ブチレ
ングリコール
4.0(3)オレイルアル
コール
0.1(4)ポ
リオキシエチレンソルビタンモノラウリン酸エステル
(20E.O.)
1.5(5)ポリ
オキシエチレンラウリルエーテル(20E.O.)
0.5(6)エチルアルコール
10.0(7)ソルビト
ール
1.
0(8)山豆根50%エチルアルコール抽出液*1
0.5(9
)ビタミンE
0.1(10) オキシベンゾン
0.2(11)防腐剤
適 量(12)
香料
適 量(13)精製水
残 量 計
100.0*1:山豆根抽出物(試験例1のもの)を
乾燥固形分とて約8%含有したもの
<製法>
A.(3)〜(6)及び(9)〜(12)を混合溶解す
る。
B.(1)、(2)、(7)、(8)及び(13)を混
合溶解する。
C.AとBを混合して均一にする。Example 1 Lotion: <Composition>
(Weight%) (1) Glycerin
5.0(2) 1,3-butylene glycol
4.0(3) Oleyl alcohol
0.1(4) Polyoxyethylene sorbitan monolaurate
(20E.O.)
1.5(5) Polyoxyethylene lauryl ether (20E.O.)
0.5(6) Ethyl alcohol
10.0(7) Sorbitol
1.
0(8) Wild bean root 50% ethyl alcohol extract *1
0.5 (9
) vitamin E
0.1 (10) Oxybenzone
0.2 (11) Preservative
Appropriate amount (12)
fragrance
Appropriate amount (13) Purified water
Remaining amount meter
100.0*1: Contains about 8% dry solid content of wild bean root extract (from Test Example 1) <Production method> A. (3) to (6) and (9) to (12) are mixed and dissolved. B. Mix and dissolve (1), (2), (7), (8) and (13). C. Mix A and B until uniform.
【0024】実施例2 クリーム:<組成>
(重量%)(1)ミツロウ
6.0(2)セタノール
5.
0(3)還元ラノリン
8.0(4)スクワラン
37.5(5)グリセリン
モノステアレート
4.0(6)親油型モ
ノステアリン酸グリセリン
2.0(7)ポリオキシエ
チレンソルビタンモノ ラウリン酸エステル
(20E.O.)
2.0(8)合歓皮水抽出液*
2
3.0(9)防
腐剤
適 量(10)香料
適 量(11)1,3−ブチレング
リコール
5.0(12)精製水
残 量
計
100.0*2:合歓皮抽出物(試験例
1のもの)を乾燥固形分として約5%含有したもの<製
法>
A.(1)〜(7)及び(9)〜(10)を混合し、加
熱して70℃に保つ。
B.(8)、(11)及び(12)を混合し、加熱して
70℃に保つ。
C.BにAを加えて均一に乳化し、30℃まで冷却する
。Example 2 Cream: <Composition>
(Weight%) (1) Beeswax
6.0(2) Setanol
5.
0(3) Reduced lanolin
8.0(4) Squalane
37.5(5) Glycerin monostearate
4.0(6) Lipophilic glyceryl monostearate
2.0(7) Polyoxyethylene sorbitan monolaurate (20E.O.)
2.0(8) Hehuanpi water extract*
2
3.0(9) Preservatives
Appropriate amount (10) Fragrance
Appropriate amount (11) 1,3-butylene glycol
5.0 (12) Purified water
Remaining amount
total
100.0*2: Contains about 5% dry solid content of Hehuanpi extract (from Test Example 1) <Manufacturing method> A. Mix (1) to (7) and (9) to (10), heat and maintain at 70°C. B. Mix (8), (11) and (12), heat and maintain at 70°C. C. Add A to B, emulsify uniformly, and cool to 30°C.
【0025】実施例3 パック:<組成>
(重量%)(1)ポリビニルアルコール
15.0(2)カルボキシメチルセルロース
ナトリウム
5.0(3)プロピレングリコール
3.0(4)山扁豆1,3−ブチレングリ
コール抽出液*3
2.5(5)エチルアルコール
10.0(6)ウロカニン酸
0.1(7)防腐剤
適 量
(8)香料
適 量(9)精製水
残 量
計
100.0*3:山扁豆抽出物(試験例1と
同様にして得たもの)を乾燥固形分として約9%含有し
たもの
<製法>
A.(1)〜(4)、(6)及び(9)を混合し、70
℃に加熱し攪拌しながら溶解せしめる。
B.(5)、(7)及び(8)を混合する。
C.AにBを加え、混合した後、冷却する。Example 3 Pack: <Composition>
(Weight%) (1) Polyvinyl alcohol
15.0(2) Sodium carboxymethylcellulose
5.0(3) Propylene glycol
3.0 (4) Mountain bean 1,3-butylene glycol extract *3
2.5(5) Ethyl alcohol
10.0(6) Urocanic acid
0.1 (7) Preservative
Appropriate amount (8) Fragrance
Appropriate amount (9) Purified water
Remaining amount
total
100.0*3: Contains about 9% dry solid content of mountain bean extract (obtained in the same manner as Test Example 1) <Production method> A. Mix (1) to (4), (6) and (9), 70
Heat to ℃ and dissolve while stirring. B. Mix (5), (7) and (8). C. Add B to A, mix, and then cool.
【0026】実施例4 乳液:
<組成>
(重量%)(1)スクワラン
5.0(2)
ワセリン
2.0(3)ミツロウ
0.5(4)ソルビタン
セスキオレイン酸エステル
0.8(5)ポリオキシエチレ
ンオレイルエーテル(20E.O.)
1.2(6)1,3−ブチレングリコール
5.0(7)蒼耳子エーテル抽出物*4
(乾燥固形分として)
0.05(8)エチルアルコール
5.0(9)防腐剤
適 量(10
)香料
適 量(11)カルボキシビニルポリマー(1.0
%水溶液) 20.0(12)
水酸化カリウム
0
.1(13)精製水
残 量 計
100
.0*4:試験例1と同様にして抽出後、乾燥して得た
もの<製法>
A.(6)〜(8)及び(13)を加熱混合し、70℃
に保つ。
B.(1)〜(5)、(9)及び(10)を加熱・混合
し、70℃に保つ。
C.BをAに加え、混合し、さらに(11)を加えて均
一に混和した後(12)を加え均一に乳化した後30℃
まで冷却する。Example 4 Emulsion: <Composition>
(Weight%) (1) Squalane
5.0(2)
Vaseline
2.0 (3) Beeswax
0.5(4) Sorbitan sesquioleate ester
0.8(5) Polyoxyethylene oleyl ether (20E.O.)
1.2(6) 1,3-butylene glycol
5.0 (7) Blueberry ether extract *4 (as dry solid content)
0.05(8) Ethyl alcohol
5.0(9) Preservatives
Appropriate amount (10
)Fragrance
Appropriate amount (11) carboxyvinyl polymer (1.0
% aqueous solution) 20.0 (12)
potassium hydroxide
0
.. 1 (13) Purified water
Remaining amount meter
100
.. 0*4: Extracted and dried in the same manner as in Test Example 1 <Production method> A. (6) to (8) and (13) were heated and mixed at 70°C.
Keep it. B. (1) to (5), (9) and (10) are heated and mixed and kept at 70°C. C. Add B to A, mix, then add (11) and mix uniformly, add (12) and emulsify uniformly, then 30°C
Cool until cool.
【0027】試験例3 使用効果試験:本発明の
皮膚化粧料の美白効果につき、使用テストにより試験を
行った。使用テストは、それぞれ30〜40才の15名
の女性をパネルとし、毎日、朝と夜の2回、洗顔後に試
験化粧料を適量顔面に2週間にわたって塗布することに
より行った。試験化粧料は実施例2のクリーム、実施例
4の乳液及び実施例2のクリームの(8)合歓皮水抽出
液を除き、精製水で補正した以外は実施例2と同様に製
造した対照品を用いた。結果を表3に示す。なお、評価
は次の基準で行った。
・美白効果
有 効:シミ・ソバカスがほとんど目立たなくな
った。
やや有効:シミ・ソバカスがあまり目立たなくなった。
無 効:変わらない。Test Example 3 Usage Effect Test: The skin whitening effect of the skin cosmetic of the present invention was tested by use test. The usage test was conducted using a panel of 15 women aged 30 to 40, who applied an appropriate amount of the test cosmetic to their faces twice a day, once in the morning and once in the evening, after washing their faces for two weeks. The test cosmetics were the cream of Example 2, the milky lotion of Example 4, and the control product manufactured in the same manner as in Example 2 except that (8) Hehuan skin water extract of the cream of Example 2 was removed and the correction was made with purified water. was used. The results are shown in Table 3. Note that the evaluation was performed based on the following criteria.・Effective whitening effect: Spots and freckles are almost invisible. Slightly effective: Spots and freckles are less noticeable. Invalid: No change.
【0028】[0028]
【表3】[Table 3]
【0029】表3の結果より明らかなように、実施例2
のクリーム及び実施例4の乳液の使用により、シミ、ソ
バカスが目立たなくなったという効果が高い有効率を持
って確認された。また、実施例1の化粧水及び実施例3
のパックについても、ほぼ同様の使用テストを行った結
果、同様の効果が得られた。As is clear from the results in Table 3, Example 2
The use of the cream of Example 4 and the emulsion of Example 4 was confirmed to have a high effectiveness rate in making spots and freckles less noticeable. In addition, the lotion of Example 1 and Example 3
We conducted almost the same usage test for the pack and found similar results.
【0030】実施例5
実施例1の成分(8)として山扁豆50%エチルアルコ
ール抽出液(山扁豆抽出物を乾燥固形分として約7%含
有するもの)を0.5%配合する以外は同様にして化粧
水を得た。Example 5 Same as in Example 1 except that 0.5% of 50% ethyl alcohol extract of mountain bean (containing about 7% dry solid content of mountain bean extract) was added as component (8). Then I got the lotion.
【0031】実施例6
実施例2の成分(8)として山扁豆水抽出液(山扁豆抽
出物を乾燥固形分として約6%含有するもの)を3.0
%配合する以外は同様にしてクリームを得た。Example 6 As component (8) of Example 2, 3.0% of the water extract of mountain bean (containing about 6% of mountain bean extract as dry solid content) was used.
A cream was obtained in the same manner except that % was added.
【0032】実施例7
実施例3の成分(4)として茵ちん蒿1、3−ブチレン
グリコール抽出液(茵ちん蒿抽出物を乾燥固形分として
6%含有するもの)を3.0%配合する以外は同様にし
てパックを得た。Example 7 As the component (4) of Example 3, 3.0% of the 1,3-butylene glycol extract (containing 6% of the dry solid content of the Trifolium chinensis extract) was blended. Other than that, I got the pack in the same way.
【0033】実施例8
実施例4の成分(7)として茵ちん蒿エーテル抽出物0
.03%(乾燥固形分として)を配合する以外は同様に
して乳液を得た。Example 8 As the component (7) of Example 4, 0.
.. A milky lotion was obtained in the same manner except that 0.3% (as dry solid content) was blended.
【0034】試験例4 使用効果試験:本発明の
皮膚化粧料の皮膚老化防止効果及び肌荒れ改善効果につ
き使用テストにより試験を行った。使用テストは、30
〜55才の20名の女性をパネルとし、毎日、朝と夜の
2回、洗顔後に試験化粧料を適宜顔面に12週間にわた
って塗布することにより行った。試験化粧料は実施例6
のクリーム、実施例8の乳液及び実施例6のクリームの
(8)山扁豆水抽出液を除き、精製水で補正した以外は
実施例6と同様に製造した対照品を用いた。結果を表4
に示す。なお、評価は次の基準で行った。
・皮膚老化防止効果
有 効:肌のはり、つやが改善された。
やや有効:肌のはり、つやがやや改善された。
無 効:使用前と変化なし。
・肌あれ改善効果
有 効:肌のかさつきやあれが改善された。
やや有効:肌のかさつきやあれがやや改善された。
無 効:使用前と変化なし。Test Example 4 Usage Effect Test: The skin cosmetic composition of the present invention was tested for its anti-aging effect and skin roughness improvement effect through a use test. Usage test is 30
A panel of 20 women aged 55 to 55 years old applied the test cosmetics to their faces twice a day, once in the morning and once in the evening, for 12 weeks after washing their faces. The test cosmetic was Example 6.
Control products were used that were manufactured in the same manner as in Example 6, except that (8) Yamabian bean water extract of the cream of Example 8, the milky lotion of Example 8, and the cream of Example 6 was removed and corrected with purified water. Table 4 shows the results.
Shown below. Note that the evaluation was performed based on the following criteria.・Effective in preventing skin aging: Improved skin firmness and luster. Slightly effective: Skin firmness and luster were slightly improved. Invalid: No change from before use.・Effective for improving rough skin Effectiveness: The dryness and roughness of the skin has been improved. Slightly effective: Skin dryness and roughness were slightly improved. Invalid: No change from before use.
【0035】[0035]
【表4】[Table 4]
【0036】表4の結果より明らかなように、実施例6
のクリーム及び実施例8の乳液は皮膚の老化防止及び肌
あれに対し有効であった。As is clear from the results in Table 4, Example 6
The cream of Example 8 and the emulsion of Example 8 were effective in preventing skin aging and against rough skin.
【0037】[0037]
【発明の効果】以上詳述した如く、本発明皮膚化粧料は
、美白効果に優れているので、日焼けによる皮膚の黒色
化、シミ、ソバカスの防止・改善等幅広く適用すること
ができる。特に山扁豆及び茵ちん蒿抽出物を含む本発明
皮膚化粧料は、上記効果に加えて、皮膚の老化防止及び
肌あれ防止に優れた効果を示す。さらに本発明の皮膚化
粧料は、安定で、しかも安全であるため、安心して使用
することができる。EFFECTS OF THE INVENTION As detailed above, the skin cosmetics of the present invention have excellent whitening effects and can be widely applied to prevent and improve skin darkening, age spots, and freckles caused by sunburn. In particular, the skin cosmetics of the present invention containing mountain bean and chinensis extracts exhibit excellent effects in preventing skin aging and rough skin in addition to the above-mentioned effects. Furthermore, the skin cosmetics of the present invention are stable and safe, so they can be used with confidence.
Claims (1)
おん及び茵ちん蒿から選ばれる生薬の抽出物の一種又は
二種以上を含有することを特徴とする皮膚化粧料。1. A skin cosmetic containing one or more extracts of herbal medicines selected from wild bean root, hehuanpi, mountain bean, cang'erzi, purple onion, and 茵chinchiang.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03178277A JP3135943B2 (en) | 1990-10-11 | 1991-07-18 | Whitening agent |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2-272889 | 1990-10-11 | ||
JP27288990 | 1990-10-11 | ||
JP03178277A JP3135943B2 (en) | 1990-10-11 | 1991-07-18 | Whitening agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04342519A true JPH04342519A (en) | 1992-11-30 |
JP3135943B2 JP3135943B2 (en) | 2001-02-19 |
Family
ID=26498508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03178277A Expired - Lifetime JP3135943B2 (en) | 1990-10-11 | 1991-07-18 | Whitening agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3135943B2 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
JPH08104646A (en) * | 1993-11-18 | 1996-04-23 | Noevir Co Ltd | Tyrosinase biosynthesis inhibitor and skin-beautifying agent mixed with the same |
EP0813875A2 (en) * | 1996-06-19 | 1997-12-29 | Institute For Advanced Skin Research Inc. | Inhibition of abnormal accumulation of extracellular matrices |
JP2000143488A (en) * | 1998-11-16 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing humectant plant extract |
JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
JP2002088085A (en) * | 2000-09-11 | 2002-03-27 | Pola Chem Ind Inc | New benzdipyran derivative and skin care preparation containing the same |
WO2002047656A1 (en) * | 2000-12-15 | 2002-06-20 | Kabushiki Kaisha Yakult Honsha | Compositions for retarding skin aging |
JP2002179529A (en) * | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Composition for bleaching |
KR20020080657A (en) * | 2001-04-17 | 2002-10-26 | 주식회사 참 존 | Cosmetics comprising Albizzia bark extracts for antioxidation |
KR100443588B1 (en) * | 2002-01-25 | 2004-08-09 | 나드리화장품주식회사 | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect |
KR100512148B1 (en) * | 2002-10-12 | 2005-09-02 | 홍성재 | Functional bath cleanser composition comprising natural plant extracts and the method for preparing the same |
WO2008111763A1 (en) * | 2007-03-09 | 2008-09-18 | Korea Institute Of Oriental Medicine | Extracts of aster koraiensis, and pharmaceutical composition and functional food comprising the same |
JP2010235548A (en) * | 2009-03-31 | 2010-10-21 | Maruzen Pharmaceut Co Ltd | Antioxidant agent, anti-inflammatory agent, skin whitening ing agent, anti-aging agent, hair growing agent, and antiobesity agent, as well as cosmetic and food and drink |
JP2010275227A (en) * | 2009-05-28 | 2010-12-09 | Kose Corp | Bleaching ingredient, bleaching cosmetic and method for producing bleaching ingredient |
JP2011132195A (en) * | 2009-12-25 | 2011-07-07 | Kose Corp | Slac2-a PROTEIN LEVEL-CUTTING AGENT, myosin Va PROTEIN LEVEL-CUTTING AGENT, AND Slp2-a PROTEIN LEVEL-CUTTING AGENT |
FR3007289A1 (en) * | 2013-06-24 | 2014-12-26 | Caster | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS TO COMBAT SKIN AGING |
JP2020033271A (en) * | 2018-08-27 | 2020-03-05 | 花王株式会社 | Skin or hair blackening agent |
CN112006953A (en) * | 2019-05-30 | 2020-12-01 | 株式会社爱茉莉太平洋 | Application of folium Artemisiae Argyi extract extracted with skin caring liquid as extraction solvent |
KR102234494B1 (en) * | 2019-10-02 | 2021-03-31 | 대한민국 | Composition comprising Aster ageratoides Turcz. extract for improving cognitive function |
-
1991
- 1991-07-18 JP JP03178277A patent/JP3135943B2/en not_active Expired - Lifetime
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
JPH08104646A (en) * | 1993-11-18 | 1996-04-23 | Noevir Co Ltd | Tyrosinase biosynthesis inhibitor and skin-beautifying agent mixed with the same |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
US6068845A (en) * | 1996-06-19 | 2000-05-30 | Institute For Advanced Skin Research Inc. | Inhibition of abnormal accumulation of extra-cellular matrices |
EP0813875A3 (en) * | 1996-06-19 | 1998-12-16 | Institute For Advanced Skin Research Inc. | Inhibition of abnormal accumulation of extracellular matrices |
EP0813875A2 (en) * | 1996-06-19 | 1997-12-29 | Institute For Advanced Skin Research Inc. | Inhibition of abnormal accumulation of extracellular matrices |
JP2000143488A (en) * | 1998-11-16 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing humectant plant extract |
JP4585671B2 (en) * | 2000-09-11 | 2010-11-24 | ポーラ化成工業株式会社 | Novel benzdipyran derivative and topical skin preparation containing the same |
JP2002088085A (en) * | 2000-09-11 | 2002-03-27 | Pola Chem Ind Inc | New benzdipyran derivative and skin care preparation containing the same |
JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
JP2002179529A (en) * | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Composition for bleaching |
WO2002047656A1 (en) * | 2000-12-15 | 2002-06-20 | Kabushiki Kaisha Yakult Honsha | Compositions for retarding skin aging |
US8101211B2 (en) | 2000-12-15 | 2012-01-24 | Kabushiki Kaisha Yakult Honsha | Compositions for retarding skin aging |
KR20020080657A (en) * | 2001-04-17 | 2002-10-26 | 주식회사 참 존 | Cosmetics comprising Albizzia bark extracts for antioxidation |
KR100443588B1 (en) * | 2002-01-25 | 2004-08-09 | 나드리화장품주식회사 | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect |
KR100512148B1 (en) * | 2002-10-12 | 2005-09-02 | 홍성재 | Functional bath cleanser composition comprising natural plant extracts and the method for preparing the same |
WO2008111763A1 (en) * | 2007-03-09 | 2008-09-18 | Korea Institute Of Oriental Medicine | Extracts of aster koraiensis, and pharmaceutical composition and functional food comprising the same |
JP2010235548A (en) * | 2009-03-31 | 2010-10-21 | Maruzen Pharmaceut Co Ltd | Antioxidant agent, anti-inflammatory agent, skin whitening ing agent, anti-aging agent, hair growing agent, and antiobesity agent, as well as cosmetic and food and drink |
JP2010275227A (en) * | 2009-05-28 | 2010-12-09 | Kose Corp | Bleaching ingredient, bleaching cosmetic and method for producing bleaching ingredient |
JP2011132195A (en) * | 2009-12-25 | 2011-07-07 | Kose Corp | Slac2-a PROTEIN LEVEL-CUTTING AGENT, myosin Va PROTEIN LEVEL-CUTTING AGENT, AND Slp2-a PROTEIN LEVEL-CUTTING AGENT |
FR3007289A1 (en) * | 2013-06-24 | 2014-12-26 | Caster | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS TO COMBAT SKIN AGING |
EP2818158A1 (en) * | 2013-06-24 | 2014-12-31 | Caster | Cosmetic compositions including plant extracts for controlling skin ageing |
JP2020033271A (en) * | 2018-08-27 | 2020-03-05 | 花王株式会社 | Skin or hair blackening agent |
CN112006953A (en) * | 2019-05-30 | 2020-12-01 | 株式会社爱茉莉太平洋 | Application of folium Artemisiae Argyi extract extracted with skin caring liquid as extraction solvent |
US20200375884A1 (en) * | 2019-05-30 | 2020-12-03 | Amorepacific Corporation | Composition for skin anti-inflammation and skin moisturizing comprising artemisia extract extracted with skin cosmetic solution as a solvent |
US11491102B2 (en) * | 2019-05-30 | 2022-11-08 | Amorepacific Cornoration | Composition for skin anti-inflammation and skin moisturizing comprising artemisia extract extracted with skin cosmetic solution as a solvent |
KR102234494B1 (en) * | 2019-10-02 | 2021-03-31 | 대한민국 | Composition comprising Aster ageratoides Turcz. extract for improving cognitive function |
Also Published As
Publication number | Publication date |
---|---|
JP3135943B2 (en) | 2001-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04342519A (en) | Skin cosmetic | |
JP2000198712A (en) | Cosmetic composition | |
JPH0930946A (en) | Beautifying and whitening dermal preparation for external use | |
JPH04338313A (en) | Cosmetic | |
JPH0812560A (en) | Skin external preparation | |
JP2799603B2 (en) | Whitening cosmetics | |
JP3584489B2 (en) | External preparation for skin | |
JPH0812561A (en) | Beautifying and whitening skin preparation for external use | |
JP2000096050A (en) | Promoter for production of hyaluronic acid | |
JP3055826B2 (en) | Skin cosmetics | |
JP2000256175A (en) | Cosmetic composition | |
JP3452671B2 (en) | External preparation for skin | |
JPH0812549A (en) | Skin external preparation | |
JPH0930949A (en) | Beautifying and whitening dermal preparation for external use | |
JPH0812552A (en) | Skin external preparation | |
JPH0971522A (en) | Skin preparation for external use for lightening skin | |
JPH0930948A (en) | Beautifying and whitening dermal preparation for external use | |
JP4402274B2 (en) | Topical skin preparation | |
JPH10203922A (en) | Cosmetic | |
JP2000256174A (en) | Cosmetic composition | |
JPH05271045A (en) | Cosmetic | |
JPH0920635A (en) | Whitening skin preparation for external use | |
JPH0812550A (en) | Skin external preparation | |
JPH0812564A (en) | Skin external preparation | |
JPH0920634A (en) | Whitening skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111201 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111201 Year of fee payment: 11 |